Davide Rossi
SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
Stathis A, Mey U, Schär S, Hitz F, Pott C, Mach N, Krasniqi F, Novak U, Schmidt C, Hohloch K, Kienle D, Hess D, Moccia A, Unterhalt M, Eckhardt K, Hayoz S, Forestieri G, Rossi D, Dirnhofer S, Ceriani L, Sartori G, Bertoni F, Buske C, Zucca E, Hiddemann W. SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood Adv 2022; 6:3911-3920.
Jul 12, 2022SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma.
Jul 12, 2022Blood Adv 2022; 6:3911-3920
Stathis Anastasios, Mey Ulrich, Schär Sämi, Hitz Felicitas, Pott Christiane, Mach Nicolas, Krasniqi Fatime, Novak Urban, Schmidt Christian, Hohloch Karin, Kienle Dirk, Hess Dagmar, Moccia Alden A, Unterhalt Michael, Eckhardt Katrin, Hayoz Stefanie, Forestieri Gabriela, Rossi Davide, Dirnhofer Stefan, Ceriani Luca, Sartori Giulio, Bertoni Francesco, Buske Christian, Zucca Emanuele, Hiddemann Wolfgang
Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, Condoluci A, Bonomini L, Forestieri G, Koch R, Piffaretti D, Pini K, Pirosa M, Cittone M, Arribas A, Lucioni M, Ghilardi G, Wu W, Arcaini L, Baptista M, Bastidas G, Beà S, Boldorini R, Broccoli A, Buehler M, Canzonieri V, Cascione L, Ceriani L, Cogliatti S, Corradini P, Derenzini E, Devizzi L, Dietrich S, Elia A, Facchetti F, Gaidano G, Garcia J, Gerber B, Ghia P, Gomes da Silva M, Gritti G, Guidetti A, Hitz F, Inghirami G, Ladetto M, López-Guillermo A, Lucchini E, Maiorana A, Marasca R, Matutes E, Meignin V, Merli M, Moccia A, Mollejo M, Montalban C, Novak U, Oscier D, Passamonti F, Piazza F, Pizzolitto S, Rambaldi A, Sabattini E, Salles G, Santambrogio E, Scarfo L, Stathis A, Stussi G, Geyer J, Tapia G, Tarella C, Thieblemont C, Tousseyn T, Tucci A, Vanini G, Visco C, Vitolo U, Walewska R, Zaja F, Zenz T, Zinzani P, Khiabanian H, Calcinotto A, Bertoni F, Bhagat G, Campo E, de Leval L, Dirnhofer S, Pileri S, Piris M, Traverse-Glehen A, Tzankov A, Paulli M, Ponzoni M, Mazzucchelli L, Cavalli F, Zucca E, Rossi D. Genetic and phenotypic attributes of splenic marginal zone lymphoma. Blood 2022; 139:732-747.
Feb 3, 2022Genetic and phenotypic attributes of splenic marginal zone lymphoma.
Feb 3, 2022Blood 2022; 139:732-747
Bonfiglio Ferdinando, Bruscaggin Alessio, Guidetti Francesca, Terzi di Bergamo Lodovico, Faderl Martin Richard, Spina Valeria, Condoluci Adalgisa, Bonomini Luisella, Forestieri Gabriela, Koch Ricardo, Piffaretti Deborah, Pini Katia, Pirosa Maria Cristina, Cittone Micol Giulia, Arribas Alberto, Lucioni Marco, Ghilardi Guido, Wu Wei, Arcaini Luca, Baptista Maria Joao, Bastidas Gabriela, Beà Silvia, Boldorini Renzo, Broccoli Alessandro, Buehler Marco, Canzonieri Vincenzo, Cascione Luciano, Ceriani Luca, Cogliatti Sergio, Corradini Paolo, Derenzini Enrico, Devizzi Liliana, Dietrich Sascha, Elia Angela Rita, Facchetti Fabio, Gaidano Gianluca, Garcia Juan Fernando, Gerber Bernhard, Ghia Paolo, Gomes da Silva Maria, Gritti Giuseppe, Guidetti Anna, Hitz Felicitas, Inghirami Giorgio, Ladetto Marco, López-Guillermo Armando, Lucchini Elisa, Maiorana Antonino, Marasca Roberto, Matutes Estella, Meignin Véronique, Merli Michele, Moccia Alden, Mollejo Manuela, Montalban Carlos, Novak Urban, Oscier David Graham, Passamonti Francesco, Piazza Francesco A, Pizzolitto Stefano, Rambaldi Alessandro, Sabattini Elena, Salles Gilles Andre, Santambrogio Elisa, Scarfo Lydia, Stathis Anastasios, Stussi Georg, Geyer Julia Turbiner, Tapia Gustavo, Tarella Corrado, Thieblemont Catherine, Tousseyn Thomas, Tucci Alessandra, Vanini Giorgio, Visco Carlo, Vitolo Umberto, Walewska Renata, Zaja Francesco, Zenz Thorsten, Zinzani Pier Luigi, Khiabanian Hossein, Calcinotto Arianna, Bertoni Francesco, Bhagat Govind, Campo Elias, de Leval Laurence, Dirnhofer Stefan, Pileri Stefano A, Piris Miguel A, Traverse-Glehen Alexandra, Tzankov Alexander, Paulli Marco, Ponzoni Maurilio, Mazzucchelli Luca, Cavalli Franco, Zucca Emanuele, Rossi Davide
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Benz R, O'Meara Stern A, Cantoni N, Bargetzi M, Bianchi-Papina E, Rossi D, Passweg J, Lohri A, Berardi S, Feller A, Rauch D, Blum S, Mey U, Arn K, Andres M, Pabst T, Baumann M, Novak U, Hitz F, Hess U, Zenhaeusern R, Chalandon Y, Stussi G. Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood Adv 2020; 4:3699-3707.
Aug 11, 2020Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial
Aug 11, 2020Blood Adv 2020; 4:3699-3707
Benz Rudolf, O'Meara Stern Alix, Cantoni Nathan, Bargetzi Mario, Bianchi-Papina Elena, Rossi Davide, Passweg Jakob, Lohri Andreas, Berardi Simona, Feller Anita, Rauch Daniel, Blum Sabine, Mey Ulrich, Arn Kornelius, Andres Martin, Pabst Thomas, Baumann Michael, Novak Urban, Hitz Felicitas, Hess Urs, Zenhaeusern Reinhard, Chalandon Yves, Stussi Georg
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study
Ghilardi G, Ghielmini M, Wannesson L, Lerch E, Samaras P, Schanz U, Passweg J, Stussi G, Kleber M, Gerber B, Rossi D, Schmidt A, Pabst T, Jeker B, Müller R, Cairoli A, Müller A, Bargetzi M, Hitz F, Baldomero H, Heim D, Swiss Blood Stem Cell Transplantation Registry. Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study. Bone Marrow Transplant 2018
Nov 2, 2018Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry study
Nov 2, 2018Bone Marrow Transplant 2018
Ghilardi Guido, Ghielmini Michele, Wannesson Luciano, Lerch Erika, Samaras Panagiotis, Schanz Urs, Passweg Jakob R, Stussi Georg, Kleber Martina, Gerber Bernhard, Rossi Davide, Schmidt Adrian, Pabst Thomas, Jeker Barbara, Müller Rouven, Cairoli Anne, Müller Antonia M S, Bargetzi Mario, Hitz Felicitas, Baldomero Helen, Heim Dominik, Swiss Blood Stem Cell Transplantation Registry
BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma
Burkhard R, Bhagat G, Cogliatti S, Rossi D, Gaidano G, Pasqualucci L, Novak U. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. Hematol Oncol 2014
Feb 4, 2014BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma
Feb 4, 2014Hematol Oncol 2014
Burkhard Regula, Bhagat Govind, Cogliatti Sergio B., Rossi Davide, Gaidano Gianluca, Pasqualucci Laura, Novak Urban
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Chigrinova E, Ladetto M, Forconi F, Cogliatti S, Votavova H, Swerdlow S, Stilgenbauer S, Piris M, Matolcsy A, Spagnolo D, Nikitin E, Zamò A, Gattei V, Bhagat G, Ott G, Zucca E, Gaidano G, Inghirami G, Marasca R, Rinaldi A, Kwee I, Rossi D, Rancoita P, Strefford J, Oscier D, Stamatopoulos K, Papadaki T, Berger F, Young K, Murray F, Rosenquist R, Greiner T, Chan W, Orlandi E, Lucioni M, Bertoni F. Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome. Blood 2013; 122:2673-82.
Sep 4, 2013Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Sep 4, 2013Blood 2013; 122:2673-82
Chigrinova Ekaterina, Ladetto Marco, Forconi Francesco, Cogliatti Sergio B., Votavova Hana, Swerdlow Steven H, Stilgenbauer Stephan, Piris Miguel A, Matolcsy Andras, Spagnolo Dominic, Nikitin Eugene, Zamò Alberto, Gattei Valter, Bhagat Govind, Ott German, Zucca Emanuele, Gaidano Gianluca, Inghirami Giorgio, Marasca Roberto, Rinaldi Andrea, Kwee Ivo, Rossi Davide, Rancoita Paola M V, Strefford Jonathan C, Oscier David, Stamatopoulos Kostas, Papadaki Theodora, Berger Françoise, Young Ken H, Murray Fiona, Rosenquist Richard, Greiner Timothy C, Chan Wing C, Orlandi Ester M, Lucioni Marco, Bertoni Francesco
Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma
Rinaldi A, Rossi D, Gaidano G, Zucca E, Cavalli F, Cogliatti S, Berger F, Marasca R, Gattei V, Lucioni M, Orlandi E, Forconi F, Kwee I, Mensah A, Bertoni F. Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma. Br J Haematol 2013; 163:194-204.
Aug 21, 2013Promoter methylation patterns in Richter syndrome affect stem-cell maintenance and cell cycle regulation and differ from de novo diffuse large B-cell lymphoma
Aug 21, 2013Br J Haematol 2013; 163:194-204
Rinaldi Andrea, Rossi Davide, Gaidano Gianluca, Zucca Emanuele, Cavalli Franco, Cogliatti Sergio B., Berger Françoise, Marasca Roberto, Gattei Valter, Lucioni Marco, Orlandi Ester M, Forconi Francesco, Kwee Ivo, Mensah Afua Adjeiwaa, Bertoni Francesco